Sialylation of chitosan to mitigate Aβ toxicity

Abstract Background Amyloid beta peptide (Aβ) is the main component of plaques and is known to play a role in the development of Alzheimer's disease (AD). As a result, structures that can trap Aβ or disrupt the interaction between Aβ and cells have been researched as a way to lessen the patholo...

Full description

Bibliographic Details
Main Authors: Dhruva Dhavale, Hy K. Lai, Paityn Warwick, James E. Henry
Format: Article
Language:English
Published: SpringerOpen 2023-02-01
Series:Bulletin of the National Research Centre
Subjects:
Online Access:https://doi.org/10.1186/s42269-023-00990-6
_version_ 1811166070025748480
author Dhruva Dhavale
Hy K. Lai
Paityn Warwick
James E. Henry
author_facet Dhruva Dhavale
Hy K. Lai
Paityn Warwick
James E. Henry
author_sort Dhruva Dhavale
collection DOAJ
description Abstract Background Amyloid beta peptide (Aβ) is the main component of plaques and is known to play a role in the development of Alzheimer's disease (AD). As a result, structures that can trap Aβ or disrupt the interaction between Aβ and cells have been researched as a way to lessen the pathological effects of Aβ. Particularly, sialylated compounds that exhibit clustering effects could be advantageous. Results Through the use of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide chemistry, sialic acid (N-acetylneuraminic acid) was used to decorate a chitosan backbone. The compounds were characterized using Fourier-transform infrared spectroscopy (FTIR) and colorimetric assays. Using the model neuroblastoma cell line SH-SY5Y, the ability of these compounds to lessen the toxicity of Aβ was examined in vitro. Successful in vitro mitigation of Aβ toxicity was found to be critically dependent on the degree of sialylation. In particular, a balance between the degree of sialylation and molecular flexibility was determined to be the criteria as it allows for natural clustering. Additionally, chitosan alone demonstrated low levels of cellular toxicity with moderate levels of toxicity mitigation (comparable to low degrees of labelling). Conclusions Compounds were successfully produced, and they varied in their effectiveness in reducing Aβ's toxicity to cells in culture. The effect of molecular flexibility and clustering on toxicity mitigation is explained in this work. This shows the potential of polymeric sugars for the creation of AD treatments.
first_indexed 2024-04-10T15:46:32Z
format Article
id doaj.art-8b61287f0e314751a44788d804b63fa5
institution Directory Open Access Journal
issn 2522-8307
language English
last_indexed 2024-04-10T15:46:32Z
publishDate 2023-02-01
publisher SpringerOpen
record_format Article
series Bulletin of the National Research Centre
spelling doaj.art-8b61287f0e314751a44788d804b63fa52023-02-12T12:03:54ZengSpringerOpenBulletin of the National Research Centre2522-83072023-02-0147111610.1186/s42269-023-00990-6Sialylation of chitosan to mitigate Aβ toxicityDhruva Dhavale0Hy K. Lai1Paityn Warwick2James E. Henry3Cain Department of Chemical Engineering, Louisiana State UniversityDan F. Smith Department of Chemical and Biomolecular Engineering, Lamar UniversityDepartment of Biology, Lamar UniversityDan F. Smith Department of Chemical and Biomolecular Engineering, Lamar UniversityAbstract Background Amyloid beta peptide (Aβ) is the main component of plaques and is known to play a role in the development of Alzheimer's disease (AD). As a result, structures that can trap Aβ or disrupt the interaction between Aβ and cells have been researched as a way to lessen the pathological effects of Aβ. Particularly, sialylated compounds that exhibit clustering effects could be advantageous. Results Through the use of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide chemistry, sialic acid (N-acetylneuraminic acid) was used to decorate a chitosan backbone. The compounds were characterized using Fourier-transform infrared spectroscopy (FTIR) and colorimetric assays. Using the model neuroblastoma cell line SH-SY5Y, the ability of these compounds to lessen the toxicity of Aβ was examined in vitro. Successful in vitro mitigation of Aβ toxicity was found to be critically dependent on the degree of sialylation. In particular, a balance between the degree of sialylation and molecular flexibility was determined to be the criteria as it allows for natural clustering. Additionally, chitosan alone demonstrated low levels of cellular toxicity with moderate levels of toxicity mitigation (comparable to low degrees of labelling). Conclusions Compounds were successfully produced, and they varied in their effectiveness in reducing Aβ's toxicity to cells in culture. The effect of molecular flexibility and clustering on toxicity mitigation is explained in this work. This shows the potential of polymeric sugars for the creation of AD treatments.https://doi.org/10.1186/s42269-023-00990-6Alzheimer’s diseaseAmyloidSialic acidToxicityAggregation
spellingShingle Dhruva Dhavale
Hy K. Lai
Paityn Warwick
James E. Henry
Sialylation of chitosan to mitigate Aβ toxicity
Bulletin of the National Research Centre
Alzheimer’s disease
Amyloid
Sialic acid
Toxicity
Aggregation
title Sialylation of chitosan to mitigate Aβ toxicity
title_full Sialylation of chitosan to mitigate Aβ toxicity
title_fullStr Sialylation of chitosan to mitigate Aβ toxicity
title_full_unstemmed Sialylation of chitosan to mitigate Aβ toxicity
title_short Sialylation of chitosan to mitigate Aβ toxicity
title_sort sialylation of chitosan to mitigate aβ toxicity
topic Alzheimer’s disease
Amyloid
Sialic acid
Toxicity
Aggregation
url https://doi.org/10.1186/s42269-023-00990-6
work_keys_str_mv AT dhruvadhavale sialylationofchitosantomitigateabtoxicity
AT hyklai sialylationofchitosantomitigateabtoxicity
AT paitynwarwick sialylationofchitosantomitigateabtoxicity
AT jamesehenry sialylationofchitosantomitigateabtoxicity